Introduction
============

The intracellular ubiquitous apicomplexan, *Toxoplasma gondii* (*T. gondii*), is the causative agent of toxoplasmosis, a significant zoonosis with harsh outcomes in livestock and human being \[[@B1]\]. The feline species are the only definitive hosts, which shed unsporulated oocysts in their fecal matter and contaminate the surroundings \[[@B2]\]. Approximately, one-third of the world population is seropositive regarding *T. gondii* infection \[[@B3]\]. The protozoan employs different transmission routes, including: food/water sources contaminated with sporulated oocysts, ingestion of meat products containing tissue cysts, transplacental infection, organ transplantation, and infected blood donors \[[@B3][@B4][@B5]\]. Toxoplasmosis is asymptomatic in healthy subjects, while the clinical manifestations would emerge in immunocompromised individuals with poor prognosis. Various parameters influence the level of morbidity and mortality of *Toxoplasma* infection, comprising host\'s age, gender, immune status, close contact with cats, occupation, cultural and feeding behaviors as well as the parasite genotype \[[@B3]\].

Anti-malaria and antibacterial agents constitute the commonly prescribed drugs for toxoplasmosis treatment; however, they may entail side effects such as suppression of bone marrow, hypersensitivity, and teratogenicity. Additionally, they are only pivotal on tachyzoite stages, while there is no efficacy on chronic tissue cysts, which in turn, could be a source for disease recrudescence upon suppressed immunity \[[@B6]\]. Immunoprophylaxis is a preventive tactic through vaccination approaches, enabling the immune machinery to properly recognize, isolate, and eliminate the pathogenic agent upon exposure. Initial attempts were based on live/attenuated parasites or crude lysates \[[@B7]\]. Later, sophisticated progress in *Toxoplasma* molecular biology revealed its antigenic repertoires, comprising major surface antigens, micronemes, rhoptries, and dense granule antigens, with potential to be used as DNA and protein vaccines or prime-boost strategies. In addition to the main *T. gondii* antigens, there exists a wide array of crucial enzymes in the metabolic, transcription, and signaling pathways \[[@B7][@B8][@B9][@B10]\]. The distinct family of calcium-dependent protein kinases (CDPKs) of *Toxoplasma* plays a substantial role in the cellular invasion and egress as well as protist gliding motility. The CDPKs are exclusively expressed in the plants, apicomplexans and ciliates \[[@B10][@B11]\]. The CDPK3 is an essential enzyme for parasite egress from the host cell, calcium-based permeabilization control of parasitophorous vacuole membrane as well as the tissue cyst formation in mouse brain \[[@B12][@B13]\]. Hence, CDPK3 possesses the extensive potential to be applied for immunization strategies as previously approved \[[@B13]\].

Prediction of immunodominant epitopes of a particular molecule utilizing web-based predictive algorithms have opened new doors towards improved vaccine design and better immunization outcome \[[@B14]\]. In the current study, we have exploited a wide array of bioinformatics tools for in-depth excavation of the CDPK3 protein to find the candidate epitopes.

Materials and Methods
=====================

Amino acid sequence
-------------------

The whole amino acid sequence of CDPK3 was retrieved from the public database of ToxoDB (<https://toxodb.org/toxo/>) server for bioinformatics analysis.

Prediction of physico-chemical functions
----------------------------------------

The physico-chemical properties of CDPK3 were predicted by using the Expasy ProtParam online server (<https://web.expasy.org/protparam/>), which demonstrates the number of amino acids, protein isoelectric point (pI) and molecular weight (MW), instability index, aliphatic index (AI), calculated half-life *in vitro* and *in vivo*, extinction coefficients, total number of residues with positive and negative charges as well as the grand average of hydropathicity (GRAVY) \[[@B15]\].

Post-translational modification sites of calcium-dependent protein kinase-3
---------------------------------------------------------------------------

The post-translational modification (PTM) sites, including phosphorylation and acylation regions of the CDPK3 protein were predicted by NetPhos 3.1 (<http://www.cbs.dtu.dk/services/NetPhos/>) and CSS-Palm (<http://csspalm.biocuckoo.org/online.php>) online tools, respectively \[[@B16]\].

Transmembrane domains and subcellular localization of calcium-dependent protein kinase-3
----------------------------------------------------------------------------------------

The subcellular localization and potential transmembrane domains of *T. gondii* CDPK3 protein were predicted utilizing PSORT II (<http://psort.hgc.jp/form2.html>) and TMHMM 2.0 (<http://www.cbs.dtu.dk/services/TMHMM-2.0/>) web servers, respectively \[[@B16]\].

Prediction of secondary and tertiary structures
-----------------------------------------------

The Garnier-Osguthorpe-Robson (GOR) server (<https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_gor4.html>) predicted the secondary structure of CDPK3 protein \[[@B17]\]. Subsequently, the three-dimensional (3D) models of protein sequence were constructed by SWISS-MODEL employing a homology-modeling method (<https://swissmodel.expasy.org/>) \[[@B16][@B18]\].

Tertiary structure refinement and validation
--------------------------------------------

The GalaxyRefine web server at <http://galaxy.seoklab.org/> was employed to refine the most suitable 3D model \[[@B19]\], on the basis of CASP10-tested refinement technique \[[@B20]\]. This bioinformatics tool rehashes structure disturbance followed by total structural relaxation via dynamics simulation \[[@B21]\]. Further, the overall quality of the refined structure was confirmed in the ProSA-web at <https://prosa.services.came.sbg.ac.at/prosa.php>. This server gives a total score for each specific structure, so out of range scores indicate probable errors in the predicted protein \[[@B22]\]. In the following, Ramachandran plots of the initial and refined models were created using RAMPAGE server at (<http://mordred.bioc.cam.ac.uk/-rapper/rampage.php>) \[[@B23]\]. According to Laskowski et al. \[[@B24]\], "this server validates protein structure based on energetically allowed and disallowed dihedral angle psi (ψ) and phi (ϕ) of amino acid residues."

Prediction of linear and conformational B-cell epitopes
-------------------------------------------------------

The continuous 20-mer B-cell epitopes were predicted by ABCpred server with a threshold of 0.75% (<http://crdd.osdd.net/raghava/abcpred/>) \[[@B25]\]. Moreover, B-cell epitopes were mapped based on physico-chemical characteristics, including accessibility, flexibility, polarity, hydrophilicity, turns, exposed surface, and antigenic propensity using Bcepred web tool available at <http://crdd.osdd.net/raghava/bcepred/bcepred_submission.html> \[[@B26]\]. Another B-cell epitope prediction tool was ProtScale, which was used to graphically evaluate epitopes based on alpha helix, beta-turn, hydrophobicity, average flexibility, and percent of accessible residues (<https://web.expasy.org/protscale/>) \[[@B15]\]. Prediction of conformational B-cell epitopes was done using the ElliPro tool of the Immune Epitope Database (IEDB; <http://tools.iedb.org/ellipro>) by default options, i.e., 0.5 min-score and 6 Å max distance. This server evaluates the epitopes through protein shape, neighbor residue clustering and residual protrusion index \[[@B27]\].

Prediction of major histocompatibility complex-specific epitopes
----------------------------------------------------------------

Those peptides from CDPK3 having affinity to major histocompatibility complex (MHC)-I (<http://tools.iedb.org/mhci/>) and MHC-II (<http://tools.immuneepitope.org/mhcii>) molecules were predicted by the IEDB server (recommended method 2.22), based on the half-maximal inhibitory concentration (IC~50~) score. The 10-mer MHC-I epitopes were predicted for H2-Db, H2-Dd, H2-Kb, H2-Kd, H2-Kk, and H2-Ld mouse alleles, whereas prediction of 15-mer MHC-II epitopes was performed for H2-IAb, H2-IAd, and H2-IEd mouse alleles.

Prediction of cytotoxic T-lymphocyte epitopes
---------------------------------------------

The cytotoxic T-lymphocyte (CTL) epitopes specific to CDPK3 of *T. gondii* were analyzed and predicted by using CTLpred online server according to 75.8% accuracy and combined approach (<http://www.imtech.res.in/raghava/ctlpred/index.html>). The default settings for the prediction were artificial neural network of 0.51 and support vector machine of 0.36 \[[@B28]\].

Evaluation of antigenic and allergenic profiles
-----------------------------------------------

Protein antigenicity was estimated by two web servers: ANTIGENpro (<http://scratch.proteomics.ics.uci.edu/>) \[[@B29]\] and VaxiJen ver. 2.0 (<http://www.ddg-pharmfac.net/vaxijen/>) \[[@B30]\]. ANTIGENpro prediction, mainly relies on microarray analysis data, without dependence on alignment and pathogen. The novel alignment-free prediction of VaxiJen is exerted through an auto cross covariance-mediated sequence transformation into uniform vectors of primary amino acid properties, with prediction accuracy of 70% to 89% (<http://www.ddg-pharmfac.net/vaxijen/VaxiJen/VaxiJen_help.html>). Also, the allergenic profile of CDPK3 was predicted by AllergenFP ver. 1.0 server with a descriptor-based fingerprint method to provide 88.9% accuracy of prediction (<http://ddg-pharmfac.net/AllergenFP/>) \[[@B31]\].
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Results
=======

General features of Toxoplasma calcium-dependent protein kinase-3 gene
----------------------------------------------------------------------

The ToxoDB server was applied for *T. gondii* CDPK3 protein sequence (accession ID: TGME49_305860). This protein encompassed 537 amino acid residues with a hypothesized pI of 5.98 and MW of 60,429.82. The total number of residues with positive (Arg+Lys) and negative (Asp+Glu) charges was 72 and 81, respectively. There exist a total number of 8,472 atoms in the sequence with the extinction coefficient of 53,330 M^−1^ cm^−1^ in the water at 280 nm wavelength. The half-life of the CDPK3 was estimated at 30 hours (mammalian reticulocytes, *in vitro*), \>20 hours (yeast, *in vivo*), and \>10 hours (*Escherichia coli*, *in vivo*). According to instability calculation, the protein was classified as stable with a score of 32.03. Also, the AI and GRAVY of the protein were 79.50 and −0.508, respectively.

Prediction of post-translational modification sites of calcium-dependent protein kinase-3
-----------------------------------------------------------------------------------------

According to NetPhos 3.1 and CSS-Palm analysis, there observed nine acylation sites and 54 phosphorylation regions (serine, 30; threonine, 19; tyrosine, 5) in the sequence, rendering a total number of 63 PTM sites ([Fig. 1](#F1){ref-type="fig"}, [Table 1](#T1){ref-type="table"}).

Transmembrane domains and subcellular localization
--------------------------------------------------

Based on the TMHMM server, no transmembrane domain was detected in the CDPK3 protein ([Fig. 2](#F2){ref-type="fig"}). Furthermore, subcellular localization results were as follows: 39.1% cytoplasmic, 34.8% nuclear, 8.7% Golgi, 4.3% peroxisomal, 4.3% plasma membrane, 4.3% vesicles of secretory system, and 4.3% mitochondrial.

Secondary and tertiary structure assessment
-------------------------------------------

Elements of the secondary structure of CDPK3 including alpha helix, extended strand, and random coil were predicted using GOR IV web server, implying 251 (46.74%) alpha helix, 67 (12.48%) extended strand, and 219 (40.78%) random coil ([Fig. 3](#F3){ref-type="fig"}). The 3D construct of the simulated models of the protein was drawn by SWISS-MODEL. Totally, four models were predicted, among which the model with high coverage and 63.03% sequence identity was selected as the most suitable model. The whole details of the SWISS-MODEL analysis are illustrated in [Fig. 4](#F4){ref-type="fig"}.

Refinement and validation of tertiary structure
-----------------------------------------------

Comparison of analysis criteria of various refined models in the GalaxyRefine server demonstrated that model number 1 as the best refined structure, having GDT-HA (0.9865), RMSD (0.298), MolProbity (1.438), clash score (8.1), poor rotamers (0.0), and Rama favored (99.3), compared to other models. Subsequently, the quality of the refined model was appraised using the ProSA-web tool, indicating a Z-score of −10.31 in the crude model compared to −10.83 in the refined model. Based on Ramachandran plot analysis, there were 458 (99.3%) residues in the favored region with 3 (0.7%) and 0 (0.0%) residues in the allowed and outlier regions of the refined model, respectively. On the other hand, 449 (97.4%), 11 (2.4%), and 1 (0.2%) residues were found in favored, allowed and outlier regions of the crude model, respectively ([Fig. 5](#F5){ref-type="fig"}).

Continuous and conformational B-cell epitopes
---------------------------------------------

The high-score 20-mer linear B-cell epitopes were predicted using the ABCpred web tool ([Table 2](#T2){ref-type="table"}). Also, [Table 3](#T3){ref-type="table"} and [Fig. 6](#F6){ref-type="fig"} demonstrate continuous B-cell epitopes based on some physico-chemical properties, analyzed by Bcepred and ProtScale web servers. The results of the ElliPro analysis of conformational B-cell epitopes showed that there were six epitopes encompassing (1) 54 residues (score=0.815), (2) 40 residues (score=0.778), (3) 17 residues (score=0.763), (4) 3 residues (score=0.728), (5) 94 residues (score=0.677), and (6) 6 residues (score=0.588).

Major histocompatibility complex-binding epitopes
-------------------------------------------------

The predicted MHC-I (10-mer) and MHC-II (15-mer) epitopes were recognized based on calculated IC~50~ values for peptide-binding to mouse alleles. It is worth mentioning that the lower percentile ranks (or IC~50~ values) indicate the higher level affinity, which represents a better T-cell epitopes and vice versa ([Tables 4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}).

Cytotoxic T-lymphocyte epitope prediction
-----------------------------------------

The CTLpred server was utilized to analyze CTL-specific epitopes. Totally, 10 high-ranked 9-mer CTL epitopes were predicted in the CDPK3 protein, being embedded in [Table 6](#T6){ref-type="table"}.

Antigenic and allergenic profiles
---------------------------------

The antigenic profile of CDPK3 was predicted by ANTIGENpro and VaxiJen web servers with scores of 0.821125 and 0.5967 (threshold: 0.5). Based on AllergenFP analysis, the CDPK3 protein was evaluated as probable non-allergen.

Discussion
==========

Over a century has passed from *T. gondii* discovery, a zoonotic widespread protozoan with a special interest in pregnant women and immunosuppressed individuals \[[@B3][@B32]\]. The weak immune status of at-risk people causes tachyzoite invasion to virtually all nucleated host cells, leading to the clinical disease. On the other hand, the parasites may hide as bradyzoite stages inside tissue cysts in hosts, suggesting the risk of opportunistic infection upon suppressed immune responses \[[@B3]\]. Thus, implementing immunoprophylactic strategies is highly recommended to prevent acute and/or chronic infections. Accordingly, identification and recognition of the precise immune-mediated processes are pivotal to battle Toxoplasma. In this sense, primitive attempts date back to the 1940s, which later prompted Dye test development as the first serodiagnosis for *T. gondii* infection \[[@B33]\].

In decades later, various investigations corroborated the protective efficacy of interleukin-12, interferon-γ (IFN-γ) as well as primary T lymphocyte subsets (CD~4~^+^ and CD~8~^+^), indicating the key role of acquired, cell-mediated immunity to limit the *Toxoplasma* infection \[[@B34][@B35]\]. Although, design and application of a vaccine candidate for the aim of vaccination are not such feasible as it may pretend; a great deal of research on vaccination during the last decades is good evidence for this allegation \[[@B7][@B8][@B9]\]. The only success of Toxoplasma live immunization was the development of "Toxovax", which protects sheep from congenital infection, while such live vaccine is unsafe for human use \[[@B36]\]. Hence, attempts in the human section mostly relied on vector-based, DNA and protein vaccines, each with its own benefits and drawbacks \[[@B7]\]. Besides, employing only one antigenic compound as a vaccine candidate probably do not provide sufficient immunity; thus, multi-antigenic and/or multi-epitope vaccines would be more immunoreactive, with strong excitation of IFN-γ-producing CD8^+^ T cells and the subsequent parasite elimination \[[@B7][@B9]\].

The advent of computer science made the *in-silico* sensing of candidate epitopes of a specific sequence possible, decreasing experimental costs and facilitating high-quality vaccine design \[[@B37][@B38][@B39]\]. Designing *Neisseria meningitidis* multi-epitope-based vaccine is a leader in this novel field of research, being extended for other pathogens, including parasitic protozoa \[[@B40][@B41][@B42]\].

In *T. gondii*, a successive calcium-related molecular events exist, being mediated by a distinct family of protein kinases, called the CDPKs. Due to a lack of CDPKs expression in fungal and mammalian cells, they merit further excavation as a potential target for immunization against toxoplasmosis \[[@B10]\]. Current *in silico* study was done for bioinformatics excavation of *Toxoplasma* CDPK3 protein using a wide range of web-based tools. Based on the ProtParam output for physico-chemical properties, the 60.42 kDa CDPK3 molecule was a good antigen (poor immunogens are below 5--10 kDa) \[[@B43]\] and a stable protein with an instability index of 32.03. Regarding AI (79.50), higher scores demonstrate increased uniformity of the target protein in a wide extent of temperatures. A negative GRAVY index was obtained from the CDPK3 protein (−0.508), rendering its hydrophilic nature and better interaction in the water-based micro-molecular milieu. Particular features of a vaccine candidate would be its immunogenic and non-allergenic profiles, as shown for *T. gondii* CDPK3 protein. The PTMs are known as a set of enzymatic functions in many eukaryotes, which occur following protein biosynthesis and determines protein activity \[[@B44]\]. Herein, we predicted the phosphorylation and acylation sites of the protein using NetPhos 3.1 and CSS-Palm web servers, respectively. Accordingly, there was 54 phosphorylation and nine acylation regions in the CDPK3 sequence, with a total of 63 PTM sites which inevitably affect protein activity. The absence of transmembrane domains improves presenting antigen for humoral and cellular priming of immunity and rapid responses \[[@B45]\].

Formally, the secondary structure is determined by the hydrogen bonds pattern between carboxyl oxygen and amino hydrogen atoms in a polypeptide chain, with α-helices and β-structures as the most occurring forms \[[@B46]\]. Secondary structure analysis of the GOR IV server showed three fundamental elements, including 12.48% extended strand, 40.78% random coil, and 46.74% α-helix. The tertiary structure is defined on the basis of the bonds and interactions of side chains present in a target protein \[[@B47]\]. In this study, we used the SWISS-MODEL for the CDPK3 3D structure prediction. Subsequently, the best-fit model (sequence identity=63.03) was rehashed by GalaxyRefine server, then RAMPAGE was applied for validation of refined model number 1, with quality scores, including GDT-HA (0.9865), RMSD (0.298), MolProbity (1.438), clash score (8.1), poor rotamers (0.0), and Rama favored (99.3). The RAMPAGE output confirmed the improvements in the tertiary structure of the refined model comparable to the crude model, with 99.3% versus 97.4%, 0.7% versus 2.4%, and 0.0% versus 0.2% of residue percentages in the favored, allowed and outlier areas, respectively.

Similar to the case of most other pathogens, innate immunity to *T. gondii* paves the way for the activation of acquired immune responses, i.e., humoral and cell-mediated immunity \[[@B48]\]. In the humoral phase, *anti-Toxoplasma* antibodies, particularly immunoglobulin G are a key element to limit parasite adhesion to surface receptors on host cells. They also play as opsonizing agent for macrophages to facilitate phagocytosis. Cellular immunity, particularly IFN-γ-secreting T cells and T-CD~8~^+^ cells, are pivotal to confine parasite multiplication and reactivation of bradyzoites within tissue cysts \[[@B49][@B50]\]. Although, in a protein sequence of interest, there may be affinity to different molecular/cellular types such as B-cells, CTL and/or MHC molecules. Thus, we exploited various web-based algorithms to analyze these specific epitopes. The ABCpred analysis revealed linear B-cell epitopes 65.93% accuracy and a threshold of \>0.75. Also, B-cell continuous epitopes based on some physico-chemical options were predicted by Bcepred and ProtScale websites. ElliPro analysis demonstrated six conformational B-cell epitopes in the protein sequence, which are crucial for optimized antigen-antibody matching. Enhanced priming of T-cells would be done through better presentation of antigenic particles by antigen presenting cells. Hence, the MHC-binding affinity (IC~50~) of epitopes was evaluated by the IEDB server. As shown in our results, low percentile ranks in a specific epitope indicate higher affinity for MHC-binding. Prediction of CTL epitopes is of utmost significance for vaccine design against toxoplasmosis. According to the CTLpred server (combined approach, 75.8% accuracy), ten 9-mer epitopes were predicted to be in the protein sequence with the potential ability for CTL induction.

In conclusion, prediction of epitopes with immunoprotective characteristics through immunosensing methods is still in its infancy, though it must be considered for future works for optimizations in the vaccine design and better immunization outcomes. For the next step, it is highly recommended to construct a multi-epitope vaccine and devise *in vivo* experiments, based on the findings of current investigation using various adjuvants and in the context of different immunization protocols.
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![NetPhos server output for CDPK3 phosphorylation sites. (A) The number of predicted sites, based on S (serine), T (threonine), and Y (tyrosine). (B) Prediction diagram of CDPK3 phosphorylation sites (<http://www.cbs.dtu.dk/services/NetPhos-2.0/output.php>). CDPK3, calcium-dependent protein kinase-3.](cevr-9-146-g001){#F1}

![Bioinformatics analysis of the transmembrane domain of CDPK3 sequence (<http://www.cbs.dtu.dk/services/TMHMM-2.0/>). (A) Number of predicted TMHs: the number of predicted transmembrane helices; exp number of AAs in TMHs: the expected number of amino acids in transmembrane helices. If this number is larger than 18 it is very likely to be a transmembrane protein (*OR* have a signal peptide); Exp number--first 60 AAs: the expected number of amino acids in transmembrane helices in the first 60 amino acids of the protein. If this number more than a few, you should be warned that a predicted transmembrane helix in the N-term could be a signal peptide; total prob. of N-in: the total probability that the N-term is on the cytoplasmic side of the membrane; POSSIBLE N-term signal sequence: a warning that is produced when "Exp number--first 60 AAs" is larger than 10 (<http://www.cbs.dtu.dk/services/TMHMM-2.0/TMHMM2.0.guide.html#output>). (B) Graphical illustration of transmembrane domain analysis of CDPK3. CDPK3, calcium-dependent protein kinase-3.](cevr-9-146-g002){#F2}

![(A) GOR IV server results suggested that CDPK3 encompasses 40.78% random coil, 12.48% extended strand, and 46.74% α-helix in secondary structure; (B) graphical result of the secondary structure prediction of CDPK3 using GOR IV online server (<https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_gor4.html>). GOR, Garnier-Osguthorpe-Robson; CDPK3, calcium-dependent protein kinase-3.](cevr-9-146-g003){#F3}

![SWISS-MODEL server output (<https://swissmodel.expasy.org/>). (A) Computed three-dimensional model; (B) model-template alignment; (C) global quality estimate; (D) sequence identity and coverage; (E) comparison with non-redundant set of PDB structures; and (F) local quality estimate.](cevr-9-146-g004){#F4}

![Confirmation of the three-dimensional structure of CDPK3 by Ramachandran plots (<http://mordred.bioc.cam.ac.uk/~rapper/rampage.php>) and ProSA-web (<https://prosa.services.came.sbg.ac.at/prosa.php>). (A) Crude model: the Z-score was estimated as −10.31, with Ramachandran plot analysis of 97.4% of amino acid residues in favored region, 2.4% and 0.2% in allowed and outlier regions, respectively. (B) Refined model: the Z-score was increased to −10.83 indicating closer quality to protein structure defined by X-ray crystallography, with change in RAMPAGE results as follow: 99.3% of residues in favored regions, 0.7% in allowed regions, and 0.0% in outlier regions. CDPK3, calcium-dependent protein kinase-3; NMR, nuclear magnetic resonance.](cevr-9-146-g005){#F5}

![Linear B-cell epitopes of CDPK3 protein sequence predicted by ProtScale server (<https://web.expasy.org/protscale/>), based on percent of accessible residues (A), average flexibility (B), beta turn (C), hydrophobicity (D), and alpha helix (E). CDPK3, calcium-dependent protein kinase-3.](cevr-9-146-g006){#F6}

###### The acylation sites of CDPK3 sequence

![](cevr-9-146-i001)

  ID                                  Position   Peptide                  Score
  ----------------------------------- ---------- ------------------------ --------
  TGME49_305860 CDPK3 (*T. gondii*)   3          ^\*\*\*\*\*^MGCVHSKNPH   17.659
  TGME49_305860 CDPK3 (*T. gondii*)   93         AYGEVLLCKDKLTGA          2.928
  TGME49_305860 CDPK3 (*T. gondii*)   256        RKKYDEKCDVWSCGV          6.868
  TGME49_305860 CDPK3 (*T. gondii*)   261        EKCDVWSCGVILYIL          9.703
  TGME49_305860 CDPK3 (*T. gondii*)   270        VILYILLCGYPPFGG          3.091
  TGME49_305860 CDPK3 (*T. gondii*)   337        HPWIVKFCSQKHTDV          1.44
  TGME49_305860 CDPK3 (*T. gondii*)   457        YSEFVTVCMDKQLLL          1.777
  TGME49_305860 CDPK3 (*T. gondii*)   510        WHQVLQECDKNNDGE          0.756
  TGME49_305860 CDPK3 (*T. gondii*)   531        VEMMQKICDVKVKH^\*^       1.269

CDPK3, calcium-dependent protein kinase-3; *T. gondii*, *Toxoplasma gondii*.

###### Linear B-cell epitopes from full-length calcium-dependent protein kinase-3 protein using ABCpred server

![](cevr-9-146-i002)

  Rank   Sequence               Start position   Score
  ------ ---------------------- ---------------- -------
  1      EEALNHPWIVKFCSQKHTDV   325              0.91
  2      SEFVTVCMDKQLLLSRERLL   451              0.87
  2      SQKHTDVGKHALTGALGNMK   338              0.87
  3      SSQIEAEVDHILQSVDFDRN   426              0.86
  3      QIFRQLDNNGDGQLDRKELI   388              0.86
  3      SGTGDSGKGTGSPDTKRDSM   38               0.86
  4      PDASLEKGGQSKGSAPSSGT   21               0.85
  5      GMYITQQKAHLSDRYQRVKK   62               0.82
  6      LHKHNIVHRDLKPENLLLES   190              0.81
  6      LDEVAVLKQLDHPNIMKLYE   122              0.81
  7      RVKKLGSGAYGEVLLCKDKL   78               0.79
  7      SQKLAQAAMLFMGSKLTTLE   362              0.79
  8      GEVDFEEFVEMMQKICDVKV   516              0.78
  8      QSKGSAPSSGTGDSGKGTGS   30               0.78
  8      VGGKMKERLGTAYYIAPEVL   229              0.78
  8      LLESKSRDALIKIVDFGLSA   206              0.78
  9      YGEVLLCKDKLTGAERAIKI   87               0.77
  9      IKKSSVTTTSNSGALLDEVA   107              0.77
  10     GTGSPDTKRDSMPMTPGMYI   46               0.76
  11     QVLQECDKNNDGEVDFEEFV   505              0.75
  11     GRLFGVTEVDDETWHQVLQE   490              0.75
  11     VHSKNPHSKHAGAAGEKPDA   4                0.75
  11     KQLVKLMLTYEPSKRISAEE   307              0.75
  11     WTQVSDEAKQLVKLMLTYEP   299              0.75
  11     LKRVEKGKFSFDPPDWTQVS   284              0.75
  11     DFGLSAHFEVGGKMKERLGT   220              0.75

###### B-cell linear epitopes based on different physico-chemical parameters using Bcepred server

![](cevr-9-146-i003)

  Prediction parameter   Epitope sequence
  ---------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Hydrophilicity         HSKNPHSK; AAGEKPDAS; EKGGQSKGSAPSSGTGDSGKGTGSPDTKRDSM; GSGAYGE; SSVTTTSNSGA; LESKSRDA; RKKYDEKCD; GGQTDQEI; TQVSDEAKQ; CSQKHTDV; QLDNNGDGQLDRK; KGDTVSDLDSSQ; QQFDSDGSGKI; GVTEVDDET; QECDKNNDGEVD.
  Flexibility            CVHSKNPH; PDASLEKGGQSKGSAPSSGTGDSGKGTGSPDTKRDS; QRVKKLG; KIIKKSSVTTTSNS; IILRQKF; NLLLESKSR; FEVGGKMK; EILKRVEKGK; TQVSDEA; TYEPSKR; KFCSQKH; GNMKKFQSSQ; RQLDNNGD; DTVSDLD; QQFDSDGS; QECDKNND.
  Accessibility          VHSKNPHSKHA; AAGEKPDASLEKGGQSKGSAP; KGTGSPDTKRDSMPMT; MYITQQKAHLSDRYQRVKKLGS; KDKLTGAER; KIIKKSSVTT; LKQLDHPNIMK; YEFFEDKRNYYLV; LRQKFSEVD; TTYLHKHN; VHRDLKPENLLLESKSRDAL; GGKMKERLGTA; PEVLRKKYDEKCD; GGQTDQEILKRVEKGKF; DPPDWTQVSDEAKQLVK; LTYEPSKRISAEEALNHP; CSQKHTDVGK; GNMKKFQSSQKLAQ; KLTTLEETKELTQIFRQLDNN GDGQLDRKELIEGYRKLMQWK; QSVDFDRNGYIEY; QQFDSDGSGKITNEELGR; TEVDDETWHQ; LQECDKNNDGEVD.
  Turns                  HSKNPHSKH; TTSNSGA; QLDHPNI; QLDNNGDGQ; CDKNNDGE.
  Exposed surface        SKNPHSKH; SPDTKRDSM; DRYQRVKKL; KIIKKSS; FEDKRNYYL; HRDLKPEN; LESKSRDA; GKMKERLG; PEVLRKKYDEKCD; DQEILKRVEKGK; TYEPSKRI; NMKKFQSSQK; GQLDRKELIE; RKLMQWK; QECDKNNDGE; KVKH.
  Polarity               VHSKNPHSKHAGA; EKGGQSK; SPDTKRDSM; KAHLSDRYQRVKKLGS; KLTGAER; YEFFEDKRNYY; EVYRGGE; EIILRQKFSEV; TTYLHKHNIVHRDLKPEN; LLESKSRDA; GGKMKERLGTA; APEVLRKKYDEKCDVW; DQEILKRVEKGKF; EAKQLVK; TYEPSKRISAEEALNHP; KFCSQKHTDVGKH; KLTTLEETKELTQ; DGQLDRKELIEGYRKLMQWK; IEAEVDHI; LLLSRERLLAA; GKITNEELGRLF; VTEVDDETWHQ; ECDKNNDGEVDFEEFVEMM; CDVKVKH.
  Antigenic propensity   CVHSKNP; YGEVLLCKDKL; VLKQLDH; YYLVMEVYR; LFDEIIL; VIMKQVL; LHKHNIV; LIKIVDFGLS; KCDVWSCGVILYILLCGYPPF; QLVKLMLTY; LNHPWIVKFCSQK; EVDHILQSVDF; YSEFVTVCMDKQL; LFGVTEV; HQVLQECDK; QKICDVKVKH.

###### IC~50~ values for CDPK3 binding to MHC class I molecules obtained using the IEDB^a)^

![](cevr-9-146-i004)

  MHC-I allele^b)^   CDPK3 start--stop^c)^   Peptide sequence   CDPK3 percentile rank^d)^
  ------------------ ----------------------- ------------------ ---------------------------
  H2-Db              56--65                  SMPMTPGMYI         0.37
  181--190           KQVLSGTTYL              0.79               
  427--436           SQIEAEVDHI              1.45               
  H2-Dd              98--107                 TGAERAIKII         0.28
  156--165           YRGGELFDEI              0.76               
  407--416           IEGYRKLMQW              1.6                
  H2-Kb              368--377                AAMLFMGSKL         1.07
  218--227           IVDFGLSAHF              1.6                
  239--248           TAYYIAPEVL              2.75               
  H2-Kd              63--72                  MYITQQKAHL         1.15
  187--196           TTYLHKHNIV              3.9                
  75--84             RYQRVKKLGS              4.55               
  H2-Kk              234--243                KERLGTAYYI         0.93
  143--152           FEDKRNYYLV              1.65               
  521--530           EEFVEMMQKI              1.9                
  H2-Ld              56--65                  SMPMTPGMYI         1.8
  57--66             MPMTPGMYIT              1.8                
  133--142           HPNIMKLYEF              2.9                

IC~50~, the half-maximal inhibitory concentration; CDPK3, calcium-dependent protein kinase-3; MHC, major histocompatibility complex.

^a)^The Immune Epitope Database (<http://tools.iedb.org/mhci/>).

^b)^H2-Db, H2-Dd, H2-Kb, H2-Kd, H2-Kk, and H2-Ld alleles are mouse MHC class I molecules.

^c)^Ten amino acids for analysis was used each time.

^d)^Low percentile rank=high level binding; high percentile rank=low level binding; IC~50~ values=percentile rank.

###### IC~50~ values for CDPK3 binding to MHC class II molecules obtained using the IEDB^a)^

![](cevr-9-146-i005)

  MHC-II allele^b)^   CDPK3 start--stop^c)^   Peptide sequence   CDPK3 percentile rank^d)^
  ------------------- ----------------------- ------------------ ---------------------------
  H2-IAb              236--250                RLGTAYYIAPEVLRK    2.40
  237--251            LGTAYYIAPEVLRKK         2.50               
  235--249            ERLGTAYYIAPEVLR         3.10               
  H2-IAd              461--475                QLLLSRERLLAAFQQ    3.80
  462--476            LLLSRERLLAAFQQF         5.00               
  460--474            KQLLLSRERLLAAFQ         5.35               
  H2-IEd              311--325                KLMLTYEPSKRISAE    3.85
  137--151            MKLYEFFEDKRNYYL         3.85               
  70--84              AHLSDRYQRVKKLGS         4.30               

IC~50~, the half-maximal inhibitory concentration; CDPK3, calcium-dependent protein kinase-3; MHC, major histocompatibility complex.

^a)^The Immune Epitope Database (<http://tools.immuneepitope.org/mhcii>).

^b)^H2-IAb, H2-IAd, and H2-IEd alleles are mouse MHC class II molecules.

^c)^Fifteen amino acids for analysis was used each time.

^d)^Low percentile rank=high level binding; high percentile rank=low level binding; IC~50~ values=percentile rank.

###### Predicted CDPK3 epitopes by CTLpred^a)^

![](cevr-9-146-i006)

  Peptide rank   Start position^b)^   Sequence    Score (ANN/SVM)^c)^
  -------------- -------------------- ----------- ---------------------
  1              71                   HLSDRYQRV   0.68/1.5769321
  2              235                  ERLGTAYYI   0.95/1.1198854
  3              143                  FEDKRNYYL   0.65/1.0252087
  4              304                  DEAKQLVKL   0.80/0.71549234
  5              259                  WSCGVILYI   0.64/0.86811315
  6              123                  DEVAVLKQL   0.76/0.7451107
  7              232                  KMKERLGTA   0.92/0.58396977
  8              316                  YEPSKRISA   0.95/0.5085333
  9              327                  ALNHPWIVK   0.34/1.1046382
  10             385                  ELTQIFRQL   0.93/0.50219928

CDPK3, calcium-dependent protein kinase-3; ANN, artificial neural network; SVM, support vector machine.

^a)^CTLpred, available online at <http://www.imtech.res.in/raghava/ctlpred/index.html>.

^b)^Nine amino acids for analysis was used.

^c)^The default ANN and SVM cut-off scores were set 0.51 and 0.36, respectively.

[^1]: ^\*^These authors contributed equally to this work.
